{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:40:23Z","timestamp":1761129623206},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1186\/s12889-019-6783-4","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T05:23:19Z","timestamp":1557465799000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["An evaluation of the hepatitis C testing, care and treatment program in the country of Georgia\u2019s corrections system, December 2013 \u2013 April 2015"],"prefix":"10.1186","volume":"19","author":[{"given":"Aaron M.","family":"Harris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otar","family":"Chokoshvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Biddle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostantine","family":"Turashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maia","family":"Japaridze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma","family":"Burjanadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengiz","family":"Tsertsvadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lali","family":"Sharvadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Karchava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archil","family":"Talakvadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ketevan","family":"Chakhnashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamta","family":"Demurishvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paata","family":"Sabelashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesl","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maia","family":"Butsashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Averhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"6783_CR1","unstructured":"Hepatitis C Fact Sheet N 164. \n                    https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c\n                    \n                  ."},{"key":"6783_CR2","unstructured":"Global Burden of Disease Study C: Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015."},{"issue":"2","key":"6783_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11524-006-9032-y","volume":"83","author":"K Stvilia","year":"2006","unstructured":"Stvilia K, Tsertsvadze T, Sharvadze L, Aladashvili M, del Rio C, Kuniholm MH, Nelson KE. Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T'bilisi, Republic of Georgia. J Urban Health. 2006;83(2):289\u201398.","journal-title":"J Urban Health"},{"issue":"4","key":"6783_CR4","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","volume":"57","author":"K Mohd Hanafiah","year":"2013","unstructured":"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333\u201342.","journal-title":"Hepatology"},{"key":"6783_CR5","doi-asserted-by":"publisher","unstructured":"Hagan LM, Kasradze A, Salyer SJ, Gamkrelidze A, Alkhazashvili M, Chanturia G, et al. Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination. BMC Public Health. 2019. \n                    https:\/\/doi.org\/10.1186\/s12889-019-6784-3\n                    \n                  .","DOI":"10.1186\/s12889-019-6784-3"},{"key":"6783_CR6","unstructured":"USAID: Behavioral Surveillance Survey Report: Characteristics of high-risk behaviors and knowledge of STI\/HIV and prevalence of HIV, syphilis and hepatitis among injecting drug users in Tbilisi, Batumi, and Kutaisi, Georgia 2002\u20132006. In.; 2006."},{"issue":"10","key":"6783_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","volume":"144","author":"GL Armstrong","year":"2006","unstructured":"Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705\u201314.","journal-title":"Ann Intern Med"},{"issue":"RR-1","key":"6783_CR8","first-page":"1","volume":"52","author":"C Weinbaum","year":"2003","unstructured":"Weinbaum C, Lyerla R, Margolis HS. Centers for Disease C, Prevention: Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003;52(RR-1):1\u201336 quiz CE31\u201334.","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"6783_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/003335491412900213","volume":"129","author":"AK Varan","year":"2014","unstructured":"Varan AK, Mercer DW, Stein MS, Spaulding AC. Hepatitis C seroprevalence among prison inmates since 2001: still high but declining. Public Health Rep. 2014;129(2):187\u201395.","journal-title":"Public Health Rep"},{"issue":"5","key":"6783_CR10","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jhep.2013.01.004","volume":"58","author":"PV Perumalswami","year":"2013","unstructured":"Perumalswami PV, Factor SH, Kapelusznik L, Friedman SL, Pan CQ, Chang C, Di Clemente F, Dieterich DT. Hepatitis outreach network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities. J Hepatol. 2013;58(5):890\u20137.","journal-title":"J Hepatol"},{"issue":"28","key":"6783_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.15585\/mmwr.mm6428a2","volume":"64","author":"K Mitruka","year":"2015","unstructured":"Mitruka K, Tsertsvadze T, Butsashvili M, Gamkrelidze A, Sabelashvili P, Adamia E, Chokheli M, Drobeniuc J, Hagan L, Harris AM, et al. Launch of a Nationwide hepatitis C elimination program - Georgia, April 2015. MMWR Morb Mortal Wkly Rep. 2015;64(28):753\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"6783_CR12","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB. American Association for the Study of liver D: diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49(4):1335\u201374.","journal-title":"Hepatology"},{"issue":"6","key":"6783_CR13","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S. Sulkowski M, Torriani FJ, Dieterich DT, Thomas DL, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"issue":"11","key":"6783_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.7326\/0003-4819-158-11-201306040-00005","volume":"158","author":"R Chou","year":"2013","unstructured":"Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med. 2013;158(11):807\u201320.","journal-title":"Ann Intern Med"},{"issue":"4","key":"6783_CR15","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/hep.26387","volume":"58","author":"S Larney","year":"2013","unstructured":"Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, Rich JD, van den Bergh BJ, Degenhardt L. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology. 2013;58(4):1215\u201324.","journal-title":"Hepatology"},{"issue":"10049","key":"6783_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","volume":"388","author":"K Dolan","year":"2016","unstructured":"Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Galvani A, Kinner SA, Courtney R, McKee M, Amon JJ, Maher L, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016;388(10049):1089\u2013102.","journal-title":"Lancet"},{"issue":"20","key":"6783_CR17","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1056\/NEJMp1311941","volume":"370","author":"JD Rich","year":"2014","unstructured":"Rich JD, Allen SA, Williams BA. Responding to hepatitis C through the criminal justice system. N Engl J Med. 2014;370(20):1871\u20134.","journal-title":"N Engl J Med"},{"issue":"5","key":"6783_CR18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.drugpo.2014.01.007","volume":"25","author":"J Bouscaillou","year":"2014","unstructured":"Bouscaillou J, Champagnat J, Luhmann N, Avril E, Inaridze I, Miollany V, Labartkava K, Kirtadze I, Butsashvili M, Kamkamidze G, et al. Hepatitis C among people who inject drugs in Tbilisi, Georgia: an urgent need for prevention and treatment. Int J Drug Policy. 2014;25(5):871\u20138.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"6783_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/qjmed\/92.1.25","volume":"92","author":"SM Gore","year":"1999","unstructured":"Gore SM, Bird AG, Cameron SO, Hutchinson SJ, Burns SM, Goldberg DJ. Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours. QJM. 1999;92(1):25\u201332.","journal-title":"QJM"},{"issue":"13","key":"6783_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347(13):975\u201382.","journal-title":"N Engl J Med"},{"issue":"3","key":"6783_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1053\/jhep.2003.50364","volume":"38","author":"GL Davis","year":"2003","unstructured":"Davis GL, Wong JB, McHutchison JG, Manns MP, Harvey J, Albrecht J. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology. 2003;38(3):645\u201352.","journal-title":"Hepatology"},{"key":"6783_CR22","unstructured":"WHO: Guidelines for the Screening, Care and Treatment of Persons with Chronic Hepatitis C Infection. World Health Organization 2016."},{"issue":"3","key":"6783_CR23","first-page":"218","volume":"25","author":"V Papastergiou","year":"2012","unstructured":"Papastergiou V, Tsochatzis E, Burroughs AK. Non-invasive assessment of liver fibrosis. Ann Gastroenterol. 2012;25(3):218\u201331.","journal-title":"Ann Gastroenterol"},{"issue":"7","key":"6783_CR24","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/j.1440-1746.2010.06295.x","volume":"25","author":"JP Bate","year":"2010","unstructured":"Bate JP, Colman AJ, Frost PJ, Shaw DR, Harley HA. High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C. J Gastroenterol Hepatol. 2010;25(7):1276\u201380.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6783-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-6783-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6783-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:06:27Z","timestamp":1588964787000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-6783-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":24,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["6783"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-6783-4","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"10 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The project determined to be a routine public health activity for disease control, and therefore not to involve human subjects research, by Human Subjects Research Offices at Georgia\u2019s NCDC and CDC. All data was de-identified to protect patient confidentiality and was analyzed in Georgia in aggregated format.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"466"}}